The market for their product is nowhere near what nexus' was/is. Not in the same league, however nexus, like any other biotech can go belly up on a single negative report on test results. High risk, high gain. Don't invest more than you can afford to loose.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.